TAMPA, Fla. (Dec. 19, 2025) — A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease ...

Early cancer detection has long been one of medicine’s greatest challenges. Now, a new generation of blood tests is offering ...

The UK's National Screening Committee has recommended that only a very small group of men at high risk of prostate cancer ...

Prostate cancer kills more than 10,000 men in England each year. For decades, urologists across the country have been ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

Acupath Laboratories announced today the integration of the ArteraAI Prostate Test into its diagnostic workflows, allowing for fast and convenient delivery of treatment insights. The ArteraAI Prostate ...

At-home cancer tests are a great way to learn key information about your health without having to visit the doctor in person. This option is good for patients who dont have time to go to the doctors ...

More than 15 abstracts showcase how the Veracyte Diagnostics Platform is advancing urologic cancer care with decisions guided by Decipher Prostate and Bladder tests SOUTH SAN FRANCISCO, ...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...